Aldava, Churchi, JR. A.

HRN: 19-64-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
BENZYL PENICILLIN 1MU (VIAL)
09/29/2023
10/05/2023
IV
500,000
Q6
PSGN
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: